DIRS.INFO The most relevant business & tech news

☆ CNBC Daily Open: A mixed picture on U.S. jobs growth
▼ + stars: | 2024-03-11 | by ( Sumathi Bala | ) www.cnbc.com time to read: +2 min

This report is from today's CNBC Daily Open, our international markets newsletter. CNBC Daily Open brings investors up to speed on everything they need to know, no matter where they are. U.S. stocks retreatWall Street finished Friday's session lower as investors look ahead to key inflation data due out this week. Japan skirts technical recessionJapan avoided a technical recession as revised fourth-quarter data revealed the economy returned to growth. "My famous topless sports massage was all about showing our culture, to be honest, that we had such a flexible culture," the Malaysian businessman told CNBC.

Persons: Tony Fernandes, Tasha Keeney Organizations: Grand Central Market, CNBC, Wall, Nasdaq, Dow, Gross, AirAsia, Pfizer Locations: Los Angeles , California, U.S, Japan, Malaysian

☆ Pfizer is betting big on cancer drugs to turn business around after Covid decline – here's what to know
▼ + stars: | 2024-03-10 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +13 min

Now, the company is betting on cancer drugs to help it regain its footing after a rocky year marked by the rapid decline of its Covid business. That $43 billion Seagen acquisition doubled Pfizer's oncology drug pipeline to 60 different experimental programs. Some analysts noted that it might take a few years for some of Pfizer's cancer drugs in mid-stage development to show pivotal clinical trial data and become less risky. Revenue from the blockbuster breast cancer drug Ibrance and prostate cancer treatment Xtandi, which Pfizer shares with Astellas Pharma, has declined over the past year. They are among the most expensive prescription drugs in the U.S. Before the Seagen deal, 94% of Pfizer's cancer products were small-molecule drugs.

Persons: Wall, Seagen, Chris Boshoff, Boshoff, David Ryder, Trung Huynh, Joe Biden's, Chris Schott, Suneet Varma, RemeGe, Merck, Padcev, Guggenheim, Pfizer's, Pfizer hasn't, Dr, Mikael Dolsten, Irfan Khan Organizations: Nurphoto, Getty, Pfizer, Astellas Pharma, Guggenheim, Bloomberg, UBS, Medicare, Drug Administration, FDA, ADC, JPMorgan, Drugs, CNBC, CVS Pharmacy, Los Angeles Times Locations: Covid, Bothell , Washington, U.S, biologics, China, Eagle Rock , California

☆ OpenAI announces 'improvements' to its governance structure nearly 5 months after Sam Altman's ouster
▼ + stars: | 2024-03-09 | by ( Erin Snodgrass | Lloyd Lee | ) www.businessinsider.com time to read: +4 min

OpenAI announced Friday that it was adding three women to its board of directors. CEO Sam Altman is also rejoining the board nearly five months after he was abruptly forced out. The company has pledged to improve its governing structure in the aftermath of the ouster and reinstatement. A Thursday report from The New York Times suggested OpenAI chief technology officer Mira Murati raised concerns about Altman's leadership with board members prior to his removal. The three women join current OpenAI board members Adam D'Angelo, Larry Summers, and Bret Taylor, as well as Altman.

Persons: OpenAI, Sam Altman, —, Altman, Mira Murati, Murati, James, Sue Desmond, Hellmann, Melinda Gates, Nicole Seligman, Fidij Simo, Desmond, Seligman, Simo, Adam D'Angelo, Larry Summers, Bret Taylor Organizations: Service, The New York Times, OpenAI, University of California, Times, Melinda Gates Foundation, Global, Sony, Pfizer, Advisors, Science, Technology, Paramount Global, Meira, Inc Locations: Los Angeles, President's, Shopify

☆ EVs are eventually the way of the future, says MAI Capital's Chris Grisanti
▼ + stars: | 2024-03-08 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailEVs are eventually the way of the future, says MAI Capital's Chris GrisantiChris Grisanti, MAI Capital Management chief equity strategist, joins 'The Exchange' to discuss how to trade Hersehy, Pfizer, Bristol Myers, Albemarle, and homebuilders.

Persons: Chris Grisanti Chris Grisanti, Bristol Organizations: MAI Capital Management, Pfizer Locations: Bristol Myers, Albemarle

☆ Sam Altman rejoins OpenAI board of directors as investigation into his ouster comes to a close
▼ + stars: | 2024-03-08 | by ( Hayden Field | ) www.cnbc.com time to read: +7 min

Sam Altman, CEO of OpenAI, attends the 54th annual meeting of the World Economic Forum, in Davos, Switzerland, on Jan. 18, 2024. OpenAI on Friday announced its new board and the wrap-up of an internal investigation by U.S. law firm WilmerHale into the events leading up to OpenAI CEO Sam Altman's ouster. Sam Altman will also rejoin OpenAI's board. "We have unanimously concluded that Sam and Greg are the right leaders for OpenAI," Bret Taylor, chair of OpenAI's board, said in a release. Since then, OpenAI has announced new board members, including former Salesforce co-CEO Bret Taylor and former Treasury Secretary Larry Summers.

Persons: Sam Altman, OpenAI, WilmerHale, Sam Altman's, OpenAI's, Sue Desmond, Hellmann, Melinda Gates, Nicole Seligman, Fidji Simo, Adam D'Angelo, Larry Summers, Bret Taylor, Greg, Sam, Taylor, Altman, Bret, Larry, Mira Murati, Mira, Helen Toner, Tasha McCauley, Ilya Sutskever, Ilya, Elon Musk, Greg Brockman, Musk, –, Toner, McCauley, Altman's Organizations: Economic, Friday, Melinda Gates Foundation, Pfizer, Advisors, Science, Technology, Global, Sony, Sony Entertainment, Paramount Global, Meira, Inc, Shopify, OpenAI, Microsoft, Fortune, Lawyers, CNBC, SpaceX, Nvidia Locations: Davos, Switzerland, President's, OpenAI's San Francisco, U.S, Saudi Aramco

☆ Pharmaceutical companies behind weight-loss drugs are slimming down a new target: The Magnificent 7
▼ + stars: | 2024-03-08 | by ( Dan Defrancesco | ) www.businessinsider.com time to read: +7 min

In today's big story, we're looking at pharma companies' surging stocks and threatening tech darlings thanks to their weight-loss drugs. And it comes despite only 1% of US adults taking weight-loss drugs, according to Bank of America , which predicts that number could rise to 15% by 2035. Weight-loss drugs are also cutting more than just fat. For Wall Street, meanwhile, the equation is much simpler: Getting more people on weight-loss drugs boosts the economy. The trend, which will be powered by cash-rich mega-cap tech companies, is thanks to strong earnings growth, the bank said.

Persons: —, Joe Biden, Donald Trump —, Trump, Zhan, Eli Lilly, Tesla, Hannah Latham, Octavio Jones, Christian Rodriguez, Laura MacPherson, Jenny Chang, Rodriguez, they're, Goldman Sachs, Biden, Barry Sternlicht, Fernando Gutierrez, It's, Elon Musk, TikTok, Pete Ryan, RJ Scaringe, Dan DeFrancesco, Hallam Bullock, Jordan Parker Erb, George Glover Organizations: Service, pharma, Business, Tesla, Microsoft, JPMorgan, Pfizer, Novo Nordisk, Bank of America, Nvidia, Companies, Fed, Infrastructure Investment, Alpha, Commission, Elon, EV, Nike, Congress, White, Meta, SXSW Locations: China, US, New York, London

NEW YORK (AP) — A federal judge in Texas has ordered a 55-year-old U.S. agency that caters to minority-owned businesses to serve people regardless of race, siding with white business owners who claimed the program discriminated against them. The agency, which helps minority-owned businesses obtain financing and government contracts, now operates in 33 states and Puerto Rico. Justice Department lawyers representing Minority Business Development Agency declined to comment on the ruling, which can be appealed to the conservative-leaning 5th U.S. John F. Robinson, president of the National Minority Business Council, said the ruling is “a blow against minority owned businesses," and does nothing to help majority-owned businesses because they already enjoy access to federal resources through the Small Business Administration. "It has the potential of damaging the whole minority business sector because there will be less service available to minority-owned businesses,” Robinson said.

Persons: Mark T, Pittman, Donald Trump, Nixon, Biden, ” Pittman, Dan Lennington, ” Lennington, John F, Robinson, ” Robinson, Arian Simone, Alphonso David, David, Stanley Goldfarb, ”, “, —, David Glasgow, Graham Lee Brewer, Haleluya Hadero Organizations: —, U.S, Northern, Northern District of, U.S . Commerce Department, Infrastructure Investment, Jobs, Black, Wisconsin Institute for Law & Liberty, Justice Department, Business, Agency, Circuit, National Minority Business Council, Small Business Administration, Economic, Pfizer, The, Appeals, American Alliance for Equal Rights, Meltzer Center for Diversity, New York University’s School of Law, Supreme, AP Locations: Texas, Northern District, Northern District of Texas, Puerto Rico, New Orleans, Tennessee, Atlanta, The New York, Florida, New

☆ A man deliberately got 217 Covid shots. Here’s what happened
▼ + stars: | 2024-03-06 | by ( Mira Cheng | ) edition.cnn.com time to read: +7 min

The man, who is not named in the correspondence in compliance with German privacy rules, reported receiving 217 Covid shots between June 2021 and November 2023. Raising suspicionsAccording to his immunization history, the man got his first Covid vaccine in June 2021. The adaptive immune system is the subsection of the immune system that learns to recognize and respond to specific pathogens when you encounter them throughout your life, Miller said. Last week, the CDC updated its guidance to recommend an additional dose of the current Covid vaccine for people 65 and older. Less than a quarter of adults and only 13% of children in the US have gotten the most recently recommended Covid vaccine, according to CDC data.

Persons: hypervaccination ”, ”, Emily Happy Miller, ” Miller, “, Dr, Kilian Schober, Friedrich, hypervaccination, ” Schober, Schober, Miller, Hypervaccination, that’s, Johnson, Sanjay Gupta Organizations: CNN, Albert Einstein College of Medicine, Alexander University Erlangen, Red Cross, RTL, Pfizer, Moderna, Johnson, Sanofi, CNN Health, Centers for Disease Control, CDC Locations: Magdeburg, Nürnberg, Saxony, Dresden, Eilenburg, United States

☆ Trade Tracker: Josh Brown buys more Pfizer
▼ + stars: | 2024-03-05 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailTrade Tracker: Josh Brown buys more PfizerJosh Brown, CEO of Ritholtz Wealth Management, joins CNBC's 'Halftime Report' to explain why he believes Pfizer is one of the best opportunities in the market right now.

Persons: Josh Brown, Pfizer Josh Brown Organizations: Pfizer, Ritholtz Wealth Management

☆ This move could help protect your portfolio from volatility as stocks trade near their highs
▼ + stars: | 2024-03-05 | by ( Darla Mercado | Cfp | ) www.cnbc.com time to read: +5 min

There's a party happening in stocks in 2024, and though investors may be reluctant, it could be time to think of taking a few chips off the table. My portfolio has recovered [from 2022],'" said Marguerita Cheng, certified financial planner and CEO of Blue Ocean Global Wealth in Gaithersburg, Maryland. "I tell people we're not selling everything, but we need to give the portfolio the TLC it deserves – this is the fine-tuning of your portfolio," she added. Be tax aware: Investors may be wary of selling highly appreciated holdings within their taxable accounts, which can incur levies on capital gains. Cheng of Blue Ocean has been turning toward dividend payers, as well as small and midcap stocks.

Persons: There's, they're, Marguerita Cheng, it's, Morningstar, Carla Adams, –, Sean Lovison, Cheng, Russell, Matson, – that's, It's, Jon Ulin Organizations: Nasdaq, Dow Jones, Netflix, Blue, Global Wealth, CNBC's, CFP, Ametrine, Investors, redeploy, Pfizer, Micron Technology, Holdings, Federal Reserve, Ulin, Wealth Management Locations: Gaithersburg , Maryland, Lake Orion , Michigan, Moorestown , New Jersey, SDVY, Boise, Boca Raton , Florida

☆ How the fortune of one of America’s biggest pharmaceutical families has quietly funded conservative causes
▼ + stars: | 2024-03-03 | by ( Casey Tolan | ) edition.cnn.com time to read: +21 min

From The Searle Freedom TrustThis year, the Searle trust is poised to play an even bigger role as it empties out its coffers. Researchers who study political nonprofits say that the Searle trust has had a major impact, even as the Searle family has stayed under the radar compared to more well-known conservative benefactors. The Searle trust is one of the most prolific funders of conservative groups among all private foundations, according to a CNN analysis of nonprofit tax data. The Searle trust has given millions to the Foundation for Government Accountability, which has worked behind the scenes to push conservative policies such as stricter voting laws. Dennis, the CEO of the Searle trust, is also the chair of DonorsTrust.

Persons: Searle, Daniel C, Trump, Donald Trump, ”, Galen Hall, who’s, Kimberly Dennis, ” Searle, “, Sarah Scaife, doesn’t, Michael B, Thomas, SPN, They’ve, ” Brendan Fischer, Brendan Fischer, “ They’ve, ” Hall, Caleb Rossiter, ” Galen Hall, movement’s MAGA, It’s, Mike Pence, that’s, Dennis, Henry Ford, John D, Rockefeller, ” Fischer, Gideon, Michael Searle, ” Dennis, “ We’re, Dan, Gideon Daniel Searle, Daniel Searle, Jonathan Eig, Jack Searle, Daniel Searle’s, Gregory Pincus, John Rock, Pincus, weren’t, –, Sue, Eig, Margaret Marsh, Enovid, misoprostol, Searle –, Pfizer –, ” Daniel Searle, Donald Rumsfeld, Searles, Biden, Wade, Dobbs, Kristen Batstone Organizations: CNN, Searle Freedom Trust, University of Michigan, Sarah Scaife Foundation, Searle, American Enterprise Institute, Reason Foundation, Tax Foundation, Manhattan Institute, Cato Institute, Foundation, Government, State Policy Network, American Legislative Exchange Council, Fair, Pacific Legal Foundation, Federalist Society, Competitive Enterprise Institute, Environment Research Center, CO2 Coalition, Heartland Institute, ”, CO2, Heartland, Republican Party, movement’s, America, Policy Institute, Trump, American Freedom Foundation, Everett, FDA, Rutgers University, Pfizer, Monsanto, Heritage Foundation, Reason, Affordable, New Civil Liberties Alliance, Public Policy Center, Claremont, National Women’s Health Network, Trust, IRS Locations: Missouri, St, Louis , Missouri, California, judgeships, ”, Omaha, Metamucil, Dramamine, Puerto, Brazil, Diet Coke, America

☆ Pfizer RSV vaccine maintains protection in older adults over two seasons in trial
▼ + stars: | 2024-02-29 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +2 min

Pfizer 's vaccine against respiratory syncytial virus maintained protection for older adults across two full seasons of the disease in an ongoing late-stage clinical trial, the company announced Thursday. The shot's efficacy declined slightly compared with the levels of protection after one RSV season, but the new data suggests that the jab generally offers durable protection for adults ages 60 and above, who are more vulnerable to severe illness from RSV. The jab showed 66.7% efficacy against that condition after one RSV season. Pfizer noted that the vaccine showed consistent efficacy against RSV A and RSV B, which are the two major subtypes of the virus, after the second RSV season. Analysts don't expect the committee to make a final recommendation until June – a decision that may have huge implications for Moderna , which is hoping to launch its own RSV jab this year.

Persons: – Organizations: Pfizer, GlaxoSmithKline, Centers for Disease Control, Moderna Locations: Northern, Southern

☆ The pet drugs vets are now prescribing look a lot more like human medications
▼ + stars: | 2024-02-28 | by ( Ian Thomas | ) www.cnbc.com time to read: +7 min

If you want to understand how different the human and animal medicine and vaccine industries have historically been, you don't need to look much further than weight loss drugs. When Pfizer spun off its animal health business in 2013 creating Zoetis, about 65% of the company's business was livestock-related. That has flipped now, with 64% of the company's revenue coming from products for companion animals like cats and dogs. Peck credits the Pfizer spinoff for allowing Zoetis to better balance what the company wanted to do in animal health versus the human health side. A similar product was approved for cats, marking the first time that monoclonal antibody treatments, which have become increasingly popular for treating human illnesses, have been used to treat pet osteoarthritis pain.

Persons: Kristin Peck, Eli Lilly, Peck, Zoetis, We've, it's, We'll Organizations: CNBC, Novo Nordisk, Pfizer, AstraZeneca, FDA

☆ These stocks were analysts' top picks for 2024. How they are doing nearly 3 months in
▼ + stars: | 2024-02-27 | by ( Pia Singh | ) www.cnbc.com time to read: +3 min

Now, we're tracking how well the analysts' picks have performed just three months into the new year. About 93% of analysts surveyed by LSEG hold a buy rating on Nvidia and have an average price target of $832.52. Warner Bros. Shares of Warner Bros. are down nearly 25% in the new year, and have lost about 45% over the past 12 months. Further, Warner Bros. did not give free cash flow guidance for 2024.

Persons: drugmaker Viatris, David Einhorn, Einhorn, Max Organizations: Dow Jones Industrial, CNBC, Nvidia, drugmaker, Pfizer, Warner Bros, APA Corp, Halliburton, Caesars Entertainment Locations: LSEG

☆ Viking stock doubled Tuesday. Here's where the next moves in the obesity space could come from
▼ + stars: | 2024-02-27 | by ( Christina Cheddar Berk | In | ) www.cnbc.com time to read: +8 min

VKTX YTD mountain Viking shares year to date Then, Viking shares more than doubled in trading on Tuesday, putting the stock on pace to report a more than 300% year-to-date gain, after the company said its GLP-1/GIP receptor agonist VK2735 hit all its primary goals in a phase 2 clinical trial. The Tema Cardiovascular and Metabolic ETF (HRTS) , which is up 12% year to date, owns Novo, Lilly and Viking. Still early days Some analysts and investors admit it is still very early days for obesity treatment and many questions remain to be answered. "We continue to expect above consensus growth in the space, as we are bullish on adoption from payers and broader obesity uptake," Meacham wrote. For obesity only, Lilly has already gained a 38% share, despite only being in the market for 13 weeks, he said.

Persons: Eli Lilly, Geoff Meacham, Meacham, Lilly, Yuri Khodjamirian, Khodjamirian, Jeff Jonas, Becton Dickinson, Novo, BofA's Meacham, What's, Tema's, it's, Gabelli's Jonas, he's, William Blair, Andy Hsieh, Hsieh Organizations: Novo Nordisk, Bank of America, Centers for Disease Control, Zealand Pharma, Viking Therapeutics, Zealand, Food and Drug Administration, Novo, Metabolic, Therapeutics, Pharmaceuticals, Rock, AstraZeneca, Roche, Gabelli Funds, FDA, Viking, Merck, Pfizer Locations: U.S, Tema, Novo Nordisk's, GLP, Lilly

☆ History shows the best trade has usually been to buy the stock getting kicked out of the Dow Industrials
▼ + stars: | 2024-02-26 | by ( Samantha Subin | ) www.cnbc.com time to read: +3 min

If history is any guide, Walgreens Boots Alliance may fare better after getting tossed from the Dow Jones Industrial Average . In fact, data shows that betting on a stock that's leaving the Dow is often a better trade for investors than buying shares of a stock that's entering the 127-year-old average. What history shows Alcoa was the best-performing stock among the last 10 outgoing Dow members. For example, Honeywell International surged more than 40% one year after joining the Dow, while UnitedHealth rallied nearly 28%. General Electric , the last of the original 12 Dow stocks, plunged about 58% one year after leaving the average in 2018.

Persons: bode, Ned Davis, Goldman Sachs, —, Amgen —, UnitedHealth, DuPont de Nemours, Fred Imbert Organizations: Walgreens Boots, Dow Jones, Walgreens, Dow, General Electric, WBA, CNBC Pro, Ned Davis Research, NDR, Alcoa, HP, Bank of America, Nike, Visa, RTX Corporation, Exxon Mobil, Pfizer, Apple, Honeywell International, DuPont de Locations: U.S

☆ A 4,400,000% return and a $168 billion cash pile. Here are 6 juicy nuggets from Warren Buffett's new letter.
▼ + stars: | 2024-02-26 | by ( Theron Mohamed | ) www.businessinsider.com time to read: +5 min

Berkshire is making bank on bonds, and its $168 billion cash pile is worth more than Uber or Nike. Assets aplentyBerkshire held $561 billion of net assets at the end of December, a 19% increase from a year earlier. Berkshire's $1 trillion-plus of assets included $354 billion of stocks, $178 billion of property and equipment, $130 billion of Treasury bills, and $24 billion of inventories. That figure is larger than the value of General Electric ($167 billion), Comcast ($166 billion), Uber ($162 billion), Nike ($160 billion), Walmart ($159 billion), American Express ($156 billion), or Pfizer ($155 billion). The upshot is that on December 31, Berkshire held $354 billion of stocks, and $168 billion of cash and other short-term investments — a ratio of nearly 2:1.

Persons: Warren Buffett's, Buffett, —, Warren Buffett, you'd, Cash, Treasuries, Charlie Munger Organizations: Berkshire Hathaway's, Nike, Service, Berkshire Hathaway, Berkshire, aplenty, Berkshire's, Electric, Comcast, Walmart, American Express, Pfizer, Federal Reserve Locations: Berkshire, aplenty Berkshire, Omaha

☆ These option plays can hedge against a reversal in stock market momentum, Goldman says
▼ + stars: | 2024-02-24 | by ( Jesse Pound | In Jesse-Pound | ) www.cnbc.com time to read: +2 min

John Marshall of Goldman's derivatives research team said in a Feb. 22 note that investors can use options to position for a reversal in the momentum trade. Goldman's approach to hedging momentum is two-pronged: buying put options on high momentum stocks, and buying call options on "anti-momentum" stocks. "If a true momentum reversal were to occur, we see the potential to profit on both sides of the trade," Marshall wrote. Goldman has a sell rating on SkyWest and a neutral rating on Palantir. On the other leg of the trade, Goldman identified stocks with buy ratings from its analysts that have fallen over the past 12 months.

Persons: Goldman Sachs, John Marshall, Marshall, Goldman Organizations: Nvidia, Goldman, SkyWest, Pfizer

☆ Here are Friday's biggest analyst calls: Rivian, DraftKings, Nio, Fox, Carvana, Pfizer and more
▼ + stars: | 2024-02-23 | by ( Alex Harring | ) www.cnbc.com time to read: +9 min

Here are Friday's biggest calls on Wall Street: UBS double-downgrades Rivian The firm said to sell the electric vehicle maker's stock, joining a growing group of concerned analysts following the company's earnings report. Raymond James upgrades Carvana The investment bank moved Carvana to market perform from underperform following the fourth-quarter earnings results. Guggenheim initiates Pfizer The firm opened coverage of the biopharmaceutical stock with a buy rating and $36 price target. " Rosenblatt initiates Adeia The firm began coverage with a buy rating and $15 price target. Roth MKM initiates CPI Card Group Roth MKM started coverage of the financial technology stock with a buy rating and $40 price target.

Persons: Ross, ROST, Raymond James, EBITDA, 4Q23, Guggenheim, ATNI, Morgan Stanley, Brighthouse, Rosenblatt, Roth MKM, Fred Imbert Organizations: UBS, Barclays, CNBC, Citi, Fox, JV, Ross, Price, Pfizer, DRG, Equitable, JPMorgan, Traction, JPMorgan downgrades Locations: 1Q24, Xperi, 4Q22

☆ Pfizer's expectations have been rightsized, has potential for $5 EPS: Cantor Fitzgerald's Chen
▼ + stars: | 2024-02-22 | by ( ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailPfizer's expectations have been rightsized, has potential for $5 EPS: Cantor Fitzgerald's ChenLouise Chen, Cantor Fitzgerald, and Michael Yee, Jefferies, joins 'Power Lunch' to discuss Chen's bull case for Pfizer, Yee's bull case for Moderna, and more.

Persons: Fitzgerald's Chen Louise Chen, Cantor Fitzgerald, Michael Yee, Jefferies Organizations: Pfizer, Moderna

☆ The Rainmakers: These 20 bankers rode a choppy deals market to top the M&A charts in 2023
▼ + stars: | 2024-02-21 | by ( Alex Morrell | Reed Alexander | ) www.businessinsider.com time to read: +4 min

In 2023, the overall value of M&A transactions dipped globally to $2.9 trillion across 53,529 deals, down from $3.4 trillion across 57,830 transactions in 2022. Business Insider partnered with MergerLinks , a financial-data service that tracks deals, to present the fifth edition of "The Rainmakers," the 20 M&A bankers who orchestrated the largest deals in North America. MergerLinks tracks publicly announced deals and calculates deal values on a net basis, including both equity and debt pieces. This year’s list has a mix of returnees and first-timers and was dominated by energy bankers, including Goldman’s Sikhtian and Morgan Stanley’s Hoover. Nearly half of the bankers on this year's list worked on energy deals.

Persons: —, Scott Sheffield, Goldman Sachs, Suhail Sikhtian, Morgan Stanley, Greg Weinberger, Aaron Hoover —, Patrick Ramsey, Claudio Sauer, Hess, Goldman’s Sikhtian, Morgan Stanley’s Hoover Organizations: Service, Pioneer Natural Resources, ExxonMobil, Sheffield, Pioneer, Exxon, Business, Centerview Partners, LSEG, MergerLinks, Chevron, Centerview, Health Partners, Pfizer, & $ Locations: Sheffield, Texas, North America

☆ Here's why we would be considering buying more Eli Lilly shares if they were down Tuesday
▼ + stars: | 2024-02-13 | by ( Morgan Chittum | ) www.cnbc.com time to read: +3 min

Every weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. If Lilly shares weren't climbing higher in Tuesday's down market, we would consider buying more, given the solid fundamentals and serious growth prospects. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB.

Persons: Jim Cramer, we're, Jefferies, Palo, Eli Lilly's, Eli Lilly, We're, —, Lilly, Jim Cramer's, Jim Organizations: CNBC, Dow, Nasdaq, Wall, Palo Alto Networks, Jefferies, Palo, Pfizer, Novo Nordisk Locations: Palo Alto

☆ Federal judge tosses lobbying group's lawsuit challenging Medicare drug price negotiations
▼ + stars: | 2024-02-13 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +3 min

The decision is an early win for the Biden administration as it grapples with a flurry of other legal challenges that drugmakers have filed against the Medicare drug price negotiations. The judge's ruling won't end the legal battle over the policy, which could end up at the Supreme Court. A slate of major companies with drugs selected for negotiations, including J&J, Merck , and Bristol Myers Squibb , have filed separate lawsuits challenging the constitutionality of the price talks. The suit also argued that the price talks violate the Eighth Amendment because they include a "crippling" excise tax aimed at forcing drugmakers to accept the government-dictated price of medicines. The groups also argued that the price talks violate due process by denying pharmaceutical companies and the public input on how Medicare negotiations will be implemented.

Persons: Biden, drugmakers, Judge David Ezra of, Ezra, NICA's, Nicole Longo, PhRMA, Eli Lilly, Johnson, NICA Organizations: U.S . Department of Health, Human Services, Supreme, Medicare, Western, Western District of Texas, Pharmaceutical Research, Manufacturers of America, Global Colon Cancer Association, National, Center Association, CNBC, Pfizer, Johnson, Merck, Bristol Myers Squibb, Chamber of Commerce, Department of Health, Department of Justice Locations: Washington ,, Western District, PhRMA, Ohio

☆ Trump Complains About Possible Biden Endorsement From Taylor Swift
▼ + stars: | 2024-02-11 | by ( Maggie Astor | More About Maggie Astor | ) www.nytimes.com time to read: +1 min

Extending a weekslong right-wing meltdown over Taylor Swift’s political preferences, former President Donald J. Trump declared on Sunday that it would be “disloyal” for Ms. Swift to endorse President Biden for re-election, given that Mr. Trump signed legislation that made it easier for artists to collect royalties when their songs are streamed. “I signed and was responsible for the Music Modernization Act for Taylor Swift and all other Musical Artists,” Mr. Trump wrote on his social media platform, referring to a 2018 bill that passed Congress with near unanimous support from members of both parties. “Joe Biden didn’t do anything for Taylor, and never will. Swift urged her fans to register to vote and tens of thousands obliged, and since Mr. Kelce appeared in a Pfizer ad campaign urging people to get Covid and flu vaccines.

Persons: Taylor, Donald J, Trump, ”, Swift, Biden, “, Taylor Swift, ” Mr, “ Joe Biden didn’t, Crooked Joe Biden, Travis, — Travis Kelce, Kelce Organizations: Liberal, Kansas City Chiefs, Pfizer

☆ Weight loss drugs are still hard to find — but Novo Nordisk and Eli Lilly are trying to change that
▼ + stars: | 2024-02-10 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +8 min

Victoria Klesty | ReutersThe insatiable demand for weight loss drugs is trouncing supply, leaving many patients struggling to find the injectable treatments. The dominant weight loss drugmakers, Novo Nordisk and Eli Lilly , have said supply woes likely won't go away anytime soon, as the popularity of those medicines continues to soar. Some Wall Street analysts project that the weight loss drug market could be worth $100 billion by the end of the decade. But both Novo Nordisk and Eli Lilly gave updates on positive supply developments to investors over the last week. Other forms of weight loss drugs could helpAlternative forms of weight loss drugs could also help alleviate supply constraints in the future.

Persons: Victoria Klesty, Eli Lilly, Cantor Fitzgerald, Louise Chen, Nordisk's Wegovy, Eli Lilly's Zepbound, Goldman Sachs, Jeff Friedman, Novo, Mike Segar, Eli, Catalent, Yves Herman Yves Herman, TD Cowen, Michael Nedelcovych, Anat Ashkenazi, Cantor Fitzgerald's Chen, Morgan Stanley, Eli Lilly's, George Frey Organizations: Novo Nordisk, CNBC, Nordisk's, University of Florida, Pfizer, AstraZeneca, Roche, Food, Nordisk, Company, FDA, Novo Holdings, Wegovy, REUTERS, Reuters, U.S Locations: Oslo, Norway, Novo, U.S, Branchburg , New Jersey, Brussels, Belgium, Catalent, Concord , North Carolina, North, Germany, Indiana, Denmark, France

Search resuls for: "Pfizer"

25 mentions found